Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study

Assessing the Risk for Gout With Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes

(2020) Michael Fralick et al.   ANNALS OF INTERNAL MEDICINE

Use of oral antidiabetic drugs in Japanese working-age patients with type 2 diabetes mellitus: dosing pattern for metformin initiators

(2020) Toshiki Kameda et al.   CURRENT MEDICAL RESEARCH AND OPINION

Prevalence of muscle dysfunction concomitant with osteoporosis in a home-dwelling Danish population aged 65–93 years - The Copenhagen Sarcopenia Study

(2020) B.R. Nielsen et al.   EXPERIMENTAL GERONTOLOGY

Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Sub‐analysis of a prospective, randomized, controlled study (PRIME‐V study)

(2020) Masaya Koshizaka et al.   Journal of Diabetes Investigation

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)

(2019) Masaya Koshizaka et al.   DIABETES OBESITY & METABOLISM

Changes in Visceral and Subcutaneous Fat in Youth With Type 2 Diabetes in the TODAY Study

(2019) Ruban Dhaliwal et al.   DIABETES CARE

Screening osteoporotic femoral neck without measuring bone mineral density with the use of tartrate resistant acid phosphatase-5b and serum-creatinine-to-cystatin C ratio in Japanese postmenopausal women

(2019) Ichiro Yoshii et al.   JOURNAL OF ORTHOPAEDIC SCIENCE

Incidence and risk factors for metabolic syndrome among urban, adult Sri Lankans: a prospective, 7-year community cohort, follow-up study

(2019) Shamila T. De Silva et al.   Diabetology & Metabolic Syndrome

The impact of visceral and general obesity on vascular and left ventricular function and geometry: a cross-sectional magnetic resonance imaging study of the UK Biobank

(2019) Max J P van Hout et al.   European Heart Journal-Cardiovascular Imaging

Skeletal muscle as potential central link between sarcopenia and immune senescence

(2019) Christopher Nelke et al.   EBioMedicine

Comparative study of the effects of ipragliflozin and sitagliptin on multiple metabolic variables in Japanese patients with type 2 diabetes: A multicentre, randomized, prospective, open-label, active-controlled study

(2018) Yuya Tsurutani et al.   DIABETES OBESITY & METABOLISM

Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes

(2018) Seigo Sugiyama et al.   Journal of Atherosclerosis and Thrombosis

Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients

(2018) Yuki Fukuoka et al.   Journal of Diabetes Investigation

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

(2017) Bruce Neal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of ipragliflozin and metformin for visceral fat reduction in patients with type 2 diabetes receiving treatment with dipeptidyl peptidase-4 inhibitors in Japan: a study protocol for a prospective, multicentre, blinded-endpoint phase IV randomised controlled trial (PRIME-V study)

(2017) Masaya Koshizaka et al.   BMJ Open

Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project

(2016) Vasant Hirani et al.   AGE AND AGEING

Associations of Sarcopenic Obesity and Dynapenic Obesity with Bone Mineral Density and Incident Fractures Over 5–10 Years in Community-Dwelling Older Adults

(2016) David Scott et al.   CALCIFIED TISSUE INTERNATIONAL

Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy

(2016) Chiho Yamamoto et al.   ENDOCRINE JOURNAL

Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives

(2016) Yutaka Seino et al.   Journal of Diabetes Investigation

Exercise-stimulated interleukin-15 is controlled by AMPK and regulates skin metabolism and aging

(2015) Justin D. Crane et al.   AGING CELL

The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans

(2015) Lingling Fang et al.   Adipocyte

Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin-stimulated glucose uptake in mouse soleus muscle

(2014) Jonas Møller Kristensen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Short-term intervention reduces bioelectrical impedance analysis-measured visceral fat in type 2 diabetes mellitus

(2014) Miwa Ryo et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Metformin—mode of action and clinical implications for diabetes and cancer

(2014) Ida Pernicova et al.   Nature Reviews Endocrinology

Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study)

(2010) Aki Hiuge-Shimizu et al.   ANNALS OF MEDICINE

Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk

(2010) M. C. Amato et al.   DIABETES CARE